Evidence map›Paper›PMID 41846284›Full record

ArticleGenetics research2026

Molecular Profiling of Germline Variants in the DNA Mismatch Repair Genes in Chinese Colorectal Cancer Patients.

Xiu Zhu, Da Han, Jun Chen, Jingjing Xu, Jiaoyue Jin, Qian Lai, Lina Xie, Jianfei Fang, Liu Zhu, Ying Yu and 6 more

Abstract read
In one paragraph

Article in Genetics research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Xiu ZhuZhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, China, cas.cn.ORCID 0000-0002-5945-0941
Da HanDepartment of Research and Development, Beijing SinoMDgene Technology Co., Ltd, Beijing, China.ORCID 0000-0002-1247-9528
Jun ChenDepartment of Pathology, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, China, nju.edu.cn.
Jingjing XuZhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, China, cas.cn.
Jiaoyue JinZhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, China, cas.cn.
Qian LaiZhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, China, cas.cn.
Lina XieZhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, China, cas.cn.
Jianfei FangZhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, China, cas.cn.ORCID 0000-0002-8761-6101
Liu ZhuDepartment of Research and Development, Beijing SinoMDgene Technology Co., Ltd, Beijing, China.
Ying YuDepartment of Research and Development, Beijing SinoMDgene Technology Co., Ltd, Beijing, China.
Jun YangDepartment of Pathology, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, China, nju.edu.cn.
Taoli WangDepartment of Pathology, Zhuzhou Central Hospital, Zhuzhou, Hunan, China, zzszxyy.cn.
Xueping XiangDepartment of Pathology, The Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou, China, z2hospital.com.
Xuejiang ShiDepartment of Research and Development, Beijing SinoMDgene Technology Co., Ltd, Beijing, China.ORCID 0009-0003-7724-8995
Desheng XiaoDepartment of Pathology, Xiangya Hospital Central South University, Changsha, Hunan, China, csu.edu.cn.ORCID 0000-0003-2204-5042
Dan SuZhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, China, cas.cn.ORCID 0000-0002-8423-1994

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundA multicenter study on the DNA mismatch repair (MMR) genes enabled us to study the profiling of germline variants in MMR genes of colorectal cancer (CRC) patients with MMR deficiency (dMMR). The clinicopathological differences between Lynch syndrome (LS) patients and sporadic dMMR CRC patients were compared by Student's t-test and χ

methodsA total of 326 CRC patients with dMMR were enrolled. Next-generation sequencing (NGS) and Sanger sequencing were performed using tumor-adjacent tissues of enrolled patients. Four MMR genes (MLH1, MSH2, MSH6, and PMS2) are included in the NGS panel.

resultsA total of 113 germline variants were detected, including 81 pathogenic and likely pathogenic variants. The clinicopathologic differences between CRC patients with/without LS were observed in age, family history, lesion location, and dMMR patterns. The CRC cohort with IHC-MSH6 negative alone shows the highest prevalence rate of LS. MLH1 was detected with the most germline variants. The mutational hotspot region of MLH1 is Exon 8, Exon 4 for MSH6, Exon 11 for PMS2, and Exon 7 for MSH2. Several germline hotspots were labeled on each MMR gene sequence by fixed-size bin analysis. In addition, some variants were novel discovered based on the presence or absence of the RS number and allele frequency record.

conclusionsOur study classified the clinicopathological features between sporadic CRC patients and LS patients. More importantly, the molecular profiling of the MMR gene germline variant was experimentally elucidated, which deepens the knowledge of MMR genes and provides a new perspective for the subsequent studies on the landscape of germline variants of Chinese LS patients.

Indexed as

Colorectal NeoplasmsDNA Mismatch RepairGerm-Line MutationAdultAgedChinaColorectal Neoplasms, Hereditary NonpolyposisDNA-Binding ProteinsEast Asian PeopleFemaleHigh-Throughput Nucleotide SequencingHumansMaleMiddle AgedMismatch Repair Endonuclease PMS2MutL Protein Homolog 1DNA-Binding ProteinsG-T mismatch-binding proteinMismatch Repair Endonuclease PMS2MLH1 protein, humanMSH2 protein, humanMutL Protein Homolog 1MutS Homolog 2 ProteinPMS2 protein, humancolorectal cancer (CRC)germline variantLynch syndromeMMR

Identifiers

PMID41846284
PMCPMC13140940

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.